Taken together, our study illustrated that a new barbituric acid derivative, BA-5, inhibited tumor growth in a mouse model, and the underlying mechanism may be its regulatory function in inhibiting the AKT signaling pathway, lowering EMT occurrence and stimulating apoptosis activity. The gene discussed is AKT1; the disease is neoplasm.